NasdaqCM - Delayed Quote USD

INVO Bioscience, Inc. (INVO)

0.9143 -0.0147 (-1.58%)
At close: May 21 at 4:00 PM EDT
0.8849 -0.03 (-3.22%)
After hours: May 21 at 7:42 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,248.8360
3,020.5750
822.1960
4,160.1160
1,037.2860
Cost of Revenue
2,553.6660
1,934.4370
850.7700
145.0520
88.7600
Gross Profit
1,695.1700
1,086.1380
-28.5740
4,015.0640
948.5260
Operating Expense
7,102.2780
7,853.2930
10,597.9070
9,231.5880
6,463.4920
Operating Income
-5,407.1080
-6,767.1550
-10,626.4810
-5,216.5240
-5,514.9660
Net Non Operating Interest Income Expense
-890.6150
-925.9090
-59.1370
-1,261.7020
-2,832.3140
Other Income Expense
-752.9000
-313.7620
-204.0210
-171.9500
--
Pretax Income
-7,050.6240
-8,006.8260
-10,889.6390
-6,650.1760
-8,347.2800
Tax Provision
29.6220
27.7860
2.8720
4.7640
0.0360
Net Income Common Stockholders
-7,080.2460
-8,034.6120
-10,892.5110
-6,654.9400
-8,347.3160
Diluted NI Available to Com Stockholders
-7,080.2460
-8,034.6120
-10,892.5110
-6,654.9400
-8,347.3160
Basic EPS
-1.45
-5.13
-17.97
-12.60
-30.40
Diluted EPS
-1.45
-5.13
-17.97
-12.60
-30.40
Basic Average Shares
2,360.7940
1,565.9510
606.1300
531.6200
274.4860
Diluted Average Shares
2,360.7940
1,565.9510
606.1300
531.6200
274.4860
Total Operating Income as Reported
-5,407.1090
-6,767.1550
-10,626.4810
-5,216.5240
-5,514.9660
Total Expenses
9,655.9440
9,787.7300
11,448.6770
9,376.6400
6,552.2520
Net Income from Continuing & Discontinued Operation
-7,080.2460
-8,034.6120
-10,892.5110
-6,654.9400
-8,347.3160
Normalized Income
-6,647.9646
-7,834.3533
-10,889.7752
-6,768.5222
-8,347.3160
Interest Income
7.7850
--
0.3080
3.6570
4.1900
Interest Expense
890.6150
925.9090
59.4450
1,265.3590
2,836.5040
Net Interest Income
-890.6150
-925.9090
-59.1370
-1,261.7020
-2,832.3140
EBIT
-6,160.0090
-7,080.9170
-10,830.1940
-5,384.8170
-5,510.7760
EBITDA
-5,751.2420
-6,880.0230
-10,752.8930
-5,218.7350
-5,476.2950
Reconciled Cost of Revenue
2,553.6660
1,934.4370
850.7700
145.0520
88.7600
Reconciled Depreciation
408.7670
200.8940
77.3010
166.0820
34.4810
Net Income from Continuing Operation Net Minority Interest
-7,080.2460
-8,034.6120
-10,892.5110
-6,654.9400
-8,347.3160
Total Unusual Items Excluding Goodwill
-720.4690
-253.4920
-3.4630
155.5920
--
Total Unusual Items
-720.4690
-253.4920
-3.4630
155.5920
--
Normalized EBITDA
-5,030.7730
-6,626.5310
-10,749.4300
-5,374.3270
-5,476.2950
Tax Rate for Calcs
0.0004
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
-288.1876
-53.2333
-0.7272
42.0098
--
12/31/2020 - 11/2/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BBLG Bone Biologics Corporation
1.4600
-19.78%
 
INBS Intelligent Bio Solutions Inc.
2.3100
-5.71%
 
VVOS Vivos Therapeutics, Inc.
2.2000
-1.79%
 
AEMD Aethlon Medical, Inc.
0.4300
-0.42%
 
NUWE Nuwellis, Inc.
0.2600
+1.29%
 
BSGM BioSig Technologies, Inc.
1.8400
+3.95%
 
HSDT Helius Medical Technologies, Inc.
1.3700
0.00%
 
HSCS Heart Test Laboratories, Inc.
5.63
-4.25%
 
TNON Tenon Medical, Inc.
0.7570
-5.37%
 
NAOV NanoVibronix, Inc.
0.7500
+1.63%